/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
Despite Becton, Dickinson and Company’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.
On Monday, Hologic HOLX released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates...
Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth quarter of fiscal 2024, up 11.4% year over year. The figure topped the Zacks...
Becton Dickinson: Fiscal Q4 Earnings Snapshot
Align Technology (ALGN) is a Zacks Rank #5 (Strong Sell) that is a global leader in digital orthodontics and the creator of the Invisalign clear aligner system.Align recently reported earnings, with an...
/CNW/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today Health Canada approval of the BD...
/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.
These three companies are top choices for a dividend-growth portfolio.
Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation...
Following a slump, shares of Medtronic MDT seem to have started to recuperate, possibly banking on a gradually improving investment and research scenario, thanks to the recent monetary policy easing. Closing...